Newly Launched Raremap Helps Rare Disease Community Navigate UK Ecosystem

Rare Daily Staff

LifeArc, the self-funded UK organization focused on addressing high-risk and complex medical challenges, has partnered with Rare Disease Research UK to launch Raremap, the country’s first comprehensive directory of rare disease organizations, created to simplify navigation across a fragmented and rapidly evolving ecosystem.

The launch reflects a broader push within the UK rare disease community to improve infrastructure and connectivity, both to accelerate research and to ensure patients and families can more easily access support networks and emerging innovations.

The platform brings together a wide range of stakeholders into a single, searchable resource. Raremap includes patient advocacy groups, academic researchers, funders, healthcare providers, government bodies, and biotechnology companies. By centralizing this information, Raremap seeks to address a persistent challenge in the rare disease space: identifying who is doing what, and where opportunities for collaboration exist.

Despite significant advances in rare disease research and drug development, the landscape remains complex and often difficult to navigate, particularly for smaller patient organizations and early-stage researchers.

Raremap is designed to lower these barriers by enabling users to search and filter organizations by function, explore interconnections across the ecosystem, and better understand how different entities contribute to advancing diagnostics, treatments, and care.

The platform also allows organizations to request inclusion, supporting its development as a living resource that evolves alongside the field. As adoption grows, LifeArc and Rare Disease Research UK said they expect Raremap to become an increasingly valuable tool for identifying funding opportunities, fostering partnerships, and improving coordination across the sector.